Psych Trial Halted After Death; Curbing Phone Addiction; Most Worried Racial Group

(MedPage Today) — The FDA has halted patient enrollment in a Phase III trial of evenamide in treatment-resistant schizophrenia following the sudden death of a participant, Newron Pharmaceuticals said. Magnetic therapy for seizures achieved similar remission…